[Ghrelin and cardiovascular disease].
Shimizu
Yoshito
Y
Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute.
Nagaya
Noritoshi
N
D000818:Animals; D017209:Apoptosis; D004730:Endothelium, Vascular / Q000503:physiopathology; D004734:Energy Metabolism; D054439:Ghrelin; D013006:Growth Hormone / Q000378:metabolism; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D036361:Peptide Hormones / Q000502:physiology*; D043562:Receptors, G-Protein-Coupled / Q000502:physiology; D054440:Receptors, Ghrelin; D015398:Signal Transduction
D054439:Ghrelin; D036361:Peptide Hormones; D043562:Receptors, G-Protein-Coupled; D054440:Receptors, Ghrelin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III